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Bone marrow adipose tissue (BMAT) has recently been recognized as a distinct fat depot
with endocrine functions. However, if and how it is regulated by chronic inflammation
remains unknown. Here, we investigate the amount of white fat and BMAT in HLA-B27
transgenic rats and curdlan-challenged SKGmice, two well-established models of chronic
inflammatory spondyloarthritis (SpA). Subcutaneous and gonadal white adipose tissue
and BMAT was reduced by 65-70% and by up to 90% in both experimental models.
Consistently, B27 rats had a 2-3-fold decrease in the serum concentrations of the
adipocyte-derived cytokines adiponectin and leptin as well as a 2-fold lower
concentration of triglycerides. The bone marrow of B27 rats was further characterized
by higher numbers of neutrophils, lower numbers of erythroblast precursors, and higher
numbers of IL-17 producing CD4+ T cells. IL-17 concentration was also increased in the
serum of B27 rats. Using a cell culture model, we show that high levels of IL-17 in the
serum of B27 rats negatively impacted adipogenesis (-76%), an effect that was reversed in
the presence of neutralizing anti-IL-17 antibody. In summary, these findings show BMAT
is severely reduced in two experimental models of chronic inflammatory SpA and suggest
that IL-17 is involved in this process.
Keywords: spondyloarthritis, HLA-B27 transgenic rat, SKG mouse, bone marrow fat, IL-17INTRODUCTION
Bone marrow adipose tissue (BMAT) has been recently recognized as a unique fat depot (1, 2).
While white adipose tissue is crucial for systemic metabolic homeostasis and brown adipose tissue
controls adaptive thermogenesis, the role of BMAT remains incompletely understood. Previous
studies have shown that bone marrow adipocytes (BMAds) are morphologically similar to white
adipocytes with large unilocular lipid droplets, albeit transcriptional analysis revealed a detectable
expression of brown adipocyte markers as well (3, 4). Also, BMAds have been recognized as
metabolically active cells that secrete adipokines, growth factors, and proinflammatory cytokinesorg June 2021 | Volume 12 | Article 6652081
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and tissue remodeling. In fact, BMAds have been recently shown
to control bone remodeling and bone mass maintenance (7, 8).
In adulthood, BMAT can account for up to 70% of the bone
marrow cavity, and it is further increased in diverse clinical
conditions, including obesity, type 2 diabetes, anorexia, and
osteoporosis (9, 10).
Although dysregulation of white adipose tissue is a common
feature of chronic inflammatory disorders, the impact of long-
term inflammation on BMAT remains elusive. In this study, we
used spondyloarthritis (SpA) as prototypical chronic
inflammatory disorders to investigate how BMAds are affected
by chronic inflammation. SpA is a group of chronic inflammatory
rheumatic diseases that affect the axial skeleton, peripheral joints,
and entheses, leading to bone erosions followed by bony ankylosis
(10). In addition, the spectrum of SpA comprises frequent extra-
articular features, including anterior uveitis, psoriasis, and
inflammatory bowel disease (IBD) (11). The exact etiology and
pathogenesis of SpA are still under investigation. Among various
genetic (e.g. HLA-B27 association) and immunological factors that
trigger the disease, adaptive immune cells such as CD4+ T cells
have been recognized as key drivers of chronicity in SpA (12). Of
note, numerous studies confirmed the critical role of interleukin-
17 (IL-17) and T helper (Th) 17 cell subset in joint inflammation
and disruption of bone remodeling in arthritis via the modulation
of matrix metalloproteinases and stimulation of RANKL (13–15).
In particular by attracting neutrophils and macrophages to the site
of inflammation and enhancing the production of pro-
inflammatory cytokines, IL-17 plays a significant role in the
pathogenesis of SpA (13, 16). Recently, antibodies neutralizing
IL-17, such as secukinumab and ixekizumab, became clinically
available to treat SpA, thereby providing new efficacious
therapeutic regimens for these disorders (17).
To assess how chronic inflammation may affect BMAT, we
utilized HLA-B27 transgenic rats (B27) and curdlan-challenged
SKG mice, two well-established models of SpA (18). Both models
recapitulate typical features of human SpA, including chronic
systemic inflammation and accelerated bone loss and reduced
bone strength due to stimulation of osteoclastogenesis and
suppression of bone formation (19–21). Our results show that
chronic inflammation in these models is associated with a decreased
amount of white adipose tissue and BMAT, with a significant
decrease of adipokines, such as leptin and adiponectin. Moreover,
we show in a cell culture model that high levels of pro-
inflammatory IL-17, which is detected in the serum of B27 rats,
may contribute to the suppression of adipogenesis. Thus, chronic
inflammation has a significant negative impact on BMAT.Whether
the loss of BMAT is due to inhibition of BMAT expansion or
depletion of existing stores remains to be investigated.METHODS
Animals
Two and six months old non-transgenic (NTG) and disease-
prone HLA-B27/ hb2m transgenic rats (33-3 line, Fischer (F344)Frontiers in Immunology | www.frontiersin.org 2background) of mixed gender were used in this study. Rat lines
were bred and maintained under conventional conditions at
University of Versailles-St-Quentin. Rats were kept at 21 degree
Celsius with a hygrometry of 41%. The 12 hours light cycle is
with light on 8AM to 8 PM and off 8PM to 8AM. Two to three
rats were kept in cages. All animals received water and food ad
libitum (chow: M25, Special Diet Service, Paris, France). Study
procedures were approved by the institutional animal care
committee (APAFIS-8910). After sacrifice, rats were weighed.
Subcutaneous and peri-gonadal fat mass was excised and
weighed. Disease activity score was graded from 0-3: 0=no
inflammation, 1=arthritis on one leg, 2=arthritis on both legs,
3=arthritis, and other clinical manifestations (orchitis, alopecia,
gut inflammation).
Experiments for the SKG model of AS were conducted under
a UK Home Office project license (PBFB4BA22) as previously
described (22). Mice were kept on a 12 hour light/12 hour dark
cycle at 21°C+/- 2°C with 55% humidity +/- 10%. Up to 5 mice
were kept per cage with a mixture of control and curdlan-
challenged mice in each cage. All animals received water and
food ad libitum (chow: RM3 from Special Diet Service; LBS
Biotech, UK). BALB/c ZAP-70W163C-mutant (SKG) mice were a
kind gift from S. Sakaguchi (University of Kyoto, Kyoto, Japan),
bred in house and maintained under specific pathogen-free
conditions. Disease was induced in 10-week-old female mice
using a single dose of 3 mg curdlan (b-1,3-glucan derived from
Alcaligenes faecalis variety myxogenes ; Wako, Japan)
administered intraperitoneally (i.p.). Arthritis was scored twice
a week using the following defined criteria: 0, no joint swelling;
0.5, mild swelling of wrist or ankle, 1.0, pronounced swelling of
wrist or ankle, 1.5 including swelling of at least one digit, 2
including swelling of all digits, 3 severe swelling with ankylosis.
All paws for each mouse were scored and were summed per
mouse to give an overall clinical grade for each mouse ranging
from 0 to 12. Ankle diameter and weight were measured twice
weekly. After 3 and 6 weeks, mice were sacrificed for
organ collection.
Hematologic Analysis
Peripheral blood was collected from rats by heart puncture into
heparinized capillary tubes, and complete blood counts were
performed (Sysmex, Paris, France). Hematopoietic cells in the
bone marrow were assessed using a bone marrow smear. For
that purpose, bone marrow was flushed from the tibia and
transferred to an objective slide. Bone marrow was spread using
a coverslip and after staining with May-Grünwald, cells were
counted in a blinded fashion by two experienced technicians
from the hematology department according to their
cytomorphological appearance.
Histology
Subcutaneous and gonadal fat pads, the liver, and the decalcified
femur and fourth lumbar vertebrae were fixed in 4% PBS-
buffered paraformaldehyde, dehydrated using an ascending
ethanol series, and embedded with paraffin. Sections (4 µm)
were prepared and stained for hematoxylin/eosin (HE) to assess
tissue structures. Adipocyte area and number of adipocytes wereJune 2021 | Volume 12 | Article 665208
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Decatur, USA).
μCT Analysis of Bone Marrow Adipose
Tissue Content
BMAT content was analyzed at the distal femur using osmium
staining and subsequent µCT analysis (vivaCT40, Scanco
Medical, Brüttisellen, Switzerland). Femurs from mice and rats
were fixed with 10% PBS-buffered formalin for 24 h and
decalcified in Osteosoft (Merck, Darmstadt, Germany). After
decalcification, bones were scanned using the vivaCT40 using a
standard protocol to ensure complete demineralization.
Afterward, bones were incubated with 2% osmium tetroxide
(Sigma-Aldrich, Mannheim, Germany) dissolved in 0.1 M
sodium cacodylate buffer (Sigma-Aldrich, Mannheim,
Germany) for 1 h at room temperature. Specimens were
washed and immediately scanned using the µCT with an X-ray
energy of 55 keV, 300 ms integration time, and an isotropic voxel
size of 10.5 µm. The fat volume (FV) in the rats was calculated
from 700 slices using manual contouring and the Scanco bone
evaluation software. The threshold was set to 448 mg HA/cm3. In
mice, 400 slices were used with a threshold of 180 mg HA/cm3.
Flow Cytometric Analysis
Mesenteric lymph nodes and bone marrow from one tibia were
collected from NTG and B27 rats. Cell suspensions were
prepared and resuspended in RPMI 1640 media (Gibco)
containing 10% fetal bovine serum, 2% sodium pyruvate, 0.05
mM 2‐mercaptoethanol, and 5 mM HEPES. To determine
intracellular cytokine production, cells were stimulated with
PMA and ionomycin (both at 500 ng/ml) in the presence of
brefeldin A (10 mg/ml) for 4 hours. First, cells were stained with
live-dead fixable reagent (Thermo Fisher) to exclude dead cells
from the analysis. Second, surface markers were labeled using
antibody mixtures prior to fixation and permeabilization with
Foxp3/Transcription Factor Staining Buffer Kit according to the
manufacturer instructions (Tonbo Biosciences). Surface marker
antibodies were CD45 (OX-1 clone, BD-Biosciences), CD3 (1F4
clone, BD-Biosciences), TCRab (R73 clone, BD-Biosciences),
and CD4 (Ox35 clone, Invitrogen). Then, cells were stained for
intracellular IL-17 (TC11-18H10 clone, BD Horizon) and Foxp3
(FJK-16S clone, Invitrogen) for 30 minutes at 4°C. Eight-
parameter cytometry was performed on an LSR III Fortessa
flow cytometer (BD Biosciences) with FACSDiva software and
analyzed with FlowJo software version 10.6.2.
Adipocyte Cell Culture
3T3-L1 adipogenic cells were obtained from ATCC and
maintained in DMEM supplemented with 10% FCS and 1%
penicillin/streptomycin. Cells were deposited on glass coverslips
at 70% confluence and differentiated into adipocytes using
maintenance medium supplemented with 174 nM insulin, 0.5
mM 3-Isobutyl-1-methylxanthine (IBMX), 250 nM
dexamethasone, and 2 µM rosiglitazone. Cells were kept in this
medium for 3 days. Afterward, cells were switched to
maintenance medium plus 174 nM insulin for another 3 days
(post-differentiation). Thereafter, cells were kept in maintenanceFrontiers in Immunology | www.frontiersin.org 3medium until day 10. Adipocytes were stained with
LipidTox (Thermo Fisher Scientific) according to the
manufacturer’s instructions.
To determine the effects of IL-17 on adipogenic differentiation,
recombinant mouse IL-17A (R&D Systems) was added at the start
of the differentiation protocol at various concentrations (10-100
ng/ml) for the entire differentiation period.
To determine the effect of IL-17 stemming from the serum of
B27 transgenic rats, we added 5% of serum fromNTG or B27 rats
on day 3 of adipogenic differentiation for 4 days or on day 2 post-
differentiation for 2 days. Additionally, some wells received 5 µg/
ml of a neutralizing anti-mouse-IL-17A antibody or anti-IgG
(both from R&D Systems). The percentage of rat serum was
determined beforehand using a dose-response curve of NTG
serum (0-5-25-50%) by assessing its effects on adipogenesis.
Gene Expression Analysis
Long bones of NTG and B27 rats were flushed and bone marrow
was harvested for total RNA isolation using TRIzol reagent
(Invitrogen, Germany) following the manufacturer ’s
instructions. Total RNA from murine 3T3-L1 adipogenic cells
was isolated with the High Pure RNA Isolation Kit (Roche,
Germany) according to the manufacturer’s protocol and
quantified using the NanoDrop spectrophotometer (Peqlab,
Erlangen, Germany). Five hundred nanograms of RNA were
reverse transcribed using M-MLV RT RNase (H-) Point Mutant
(Promega, Mannheim, Germany) followed by SYBR Green-
based quantitative real-time PCR according to established
protocols (ABI7500 Fast; Applied Biosystems, Carlsbad, CA).
The primer sequences were: rActb S: GCTACAGCTTCA
CCACCACA, rActb AS: AGGGCAACATAGCACAGCTT;
mActb S: GATCTGGCACCACACCTTCT, mActb AS:
GGGGTGTTGAAGGTCTCAAA; rAdipoq S: AGGAAACTT
GTGCAGGTTGG, rAdipoq AS: CCTGTCATTCCAGC
ATCTCC; mAdipoq S: AAAGGAGAGCCTGGAGAAGC,
mAdipoq AS: GTAGAGTCCCGGAATGTTGC; rAdipor1 S:
CTTCTACTGCTCCCCACAGC, rAdipor1 S: ACACCACTC
AAGCCAAGTCC; mAp2 S: GATGCCTTTGTGGGAACCTG;
mAp2 AS: GAATTCCACGCCCAGTTTGA; mCebpa S:
CTGAGAGCTCCTTGGTCAAG, mCebpa AS: GAATCTCCTA
GTCCTGGCTTG; rPparg S: CCGAGAAGGAGAAGCTGTTG,
rPparg AS: TCAGCGGGAAGGACTTTATG; mPparg S:
CACTCGCATTCCTTTGACATC, mPparg AS: CGCACTT
TGGTATTCTTGGAG; (r = rat; m = mouse). PCR conditions
were: 95°C for 2 min followed by 40 cycles with 95°C for 15 sec
and 60°C for 1 min. Melting curves were assessed to confirm the
amplification of one PCR product by increasing the temperature
from 65°C to 95°C. Results were calculated based on the DDCT
method and are depicted in x-fold change normalized to the
housekeeping gene Actb.
Serum Analysis
Serum levels of glucose, triglycerides, cholesterol, and high- and
low-density lipoprotein (HDL, LDL) were measured in B27 rats
using a Roche ModularPPEanalyzer. Serum IL-17 and
adiponectin levels in B27 rats were quantified using Quantikine
ELISAs from R&D Systems.June 2021 | Volume 12 | Article 665208
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Rat serum was further used to quantify obesity-related cytokines
using the Proteome Profiler Rat Adipokine Array Kit from R&D
Systems according to the manufacturer’s protocol.
Statistical Analysis
Results are presented as individual dots with the mean indicated
as horizontal line. Comparisons were performed using unpaired
Student’s t-test, two way ANOVA, and one‐way ANOVA
followed by Tukey’s post hoc test as appropriate, by using
GraphPad Prism version 7.0. P-values ≤ 0.05 were considered
statistically significant.RESULTS
Loss of Bone Marrow Adipocytes in
HLA-B27 Transgenic Rats and SKG Mice
In the course of previous analyses that were aimed at
investigating the rate of bone loss during disease progression
in B27 rats (23), we observed that BMAds were strongly reduced
along with disease development. To investigate this further,Frontiers in Immunology | www.frontiersin.org 4we examined the BMAT content in 2-and 6-month-old B27
rats with a low degree of inflammation and established
disease (Figure 1A), respectively, using histology and osmium-
based µCT, in which osmium stains lipid droplets and due to its
heavy metal characteristics can be quantified using µCT.
Histological analysis revealed no difference in the number of
adipocytes in the femur of 2-month-old B27 rats, while 90% of
BMAT reduction was observed in the 6-month-old cohort
(Figure 1B). Analysis of the lumbar vertebral body also
showed diminished BMAT in B27 rats before and after the
onset of the disease (Figure 1C). Interestingly, loss of
adipocytes was accompanied by an increased immune cell
infiltration in the femur (6-month-old group) and lumbar
vertebral body (2- and 6-month-old groups) of B27 rats
(Figures 1D, E). µCT analysis revealed a more than a three-
fold reduction in BMAT in the bone marrow of 6-month-old B27
rats compared to NTG rats (Figure 1F, G). Furthermore, the
mRNA expression of adipocyte markers including peroxisome
proliferator-activated receptor gamma (Pparg), adiponectin
(Adipoq), and adiponectin receptor 1 (Adipor1) was strongly









FIGURE 1 | Decreased numbers of bone marrow adipocytes in B27 transgenic rats. (A) Clinical score of 2 and 6 months old NTG and B27 rats. Disease level was
graded from 0-3: 0=no inflammation, 1=arthritis on one leg, 2=arthritis on both legs, 3=severe arthritis, and other organ manifestation. (B) Number of bone marrow
adipocytes ghosts from the femur of 2- and 6 months old NTG and B27 (n=5-6 per group). (C) Number of bone marrow adipocytes ghosts from the vertebrae of 2-
and 6 months old NTG and B27 (n=5 per group). (D, E) Representative histology sections from femur and vertebrae of 2-and 6 months old NTG and B27 rats
stained with von Kossa/toluidine blue (scale bar: 100 μm) (F, G) Osmium tetroxide staining for bone marrow adipose tissue (BMAT) followed by micro-computed
tomography (mCT) analysis. Quantification of fat volume (F) and representative images (G) of stained lipids in femora of NTG and B27 rats (n=6-7 per group).
(H) Relative expression of PPARg, adiponectin, and adiponectin receptor in the bone marrow of NTG and B27 rats. Results are presented as individual dots with the
mean indicated as horizontal line (n=5-6 per group). *p < 0.05; **p < 0.01 and ***p ≤ 0.001 vs. controls via unpaired Student’s t-test.June 2021 | Volume 12 | Article 665208
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murine model of SpA, we assessed the BMAT in curdlan-
challenged SKG mice. SKG mice developed severe
inflammatory arthritis (Figures 2A, B) that was associated
with a marked reduction in BMAT content (Figure 2C) and
BMAd number (Figure 2D) at three weeks post curdlan
challenge that remained low until six weeks. Thus, BMAT is
severely reduced in two characteristic murine models of chronic
inflammatory SpA.
Chronic Inflammation in Murine Models of
SpA Is Associated With Loss of Adipose
Tissue and an Altered Metabolic Profile
To further investigate whether the decreased amount of
adipocytes in the bone marrow from B27 rats is site-specific,
we measured in these rats body weight and subcutaneous and
peri-gonadal fat weight. We observed a significant loss of body
weight (Table 1) as well as a marked reduction of subcutaneous
and peri-gonadal fat mass compared to NTG rats (Figures 3A, B).
Histological analysis of these fat pads showed that adipocyte
number was similar, but that adipocyte size was significantly
reduced in B27 rats compared to NTG rats (Figures 3A, B).
Furthermore, HE staining showed massive inflammatory
infiltrates into the adipose tissue at both sites in B27 rats
(Figures 3C, D). Importantly, these results were corroborated in
arthritic SKG mice, showing weight loss (Figure 3E) and reducedFrontiers in Immunology | www.frontiersin.org 5subcutaneous fat mass (Figure 3F). Thus, loss of BMAT is not
bone marrow-specific, but also white adipose tissue undergoes
destruction during chronic inflammation, underscoring the
consumptive or catabolic nature of unopposed chronic
inflammation. In addition to adipose tissue loss, B27 rats
showed significant reduction in serum triglycerides, cholesterol,
LDL as well as HDL (Table 1). Moreover, blood glucose levels
were decreased by 20% (Table 1). To further examine the levels of
adipokines, we performed a proteome profiler assay on NTG and
B27 rat sera. This analysis showed that adiponectin and leptin
levels, two cytokines produced mainly by adipocytes, were highly
reduced in B27 rats (Figures 4A, B). In addition, CD26, IGF-1,
LIF, and RAGE were also significantly reduced (Figure 4B).
Representative blots for cytokine expression in NTG and B27
are shown in Figure 4C. Of note, the abundance of all otherA B
D
C
FIGURE 2 | Decreased numbers of bone marrow adipocytes in SKG mice. (A, B) Clinical score of SKG animals at steady-state (SS) or curdlan-challenged (CC) for
3 and 6 weeks. (C) Osmium tetroxide staining for BMAT followed by mCT analysis. Quantification of fat volume (left) and representative images (right) of stained lipids
in femora of SKG mice at 3- and 6-weeks post-curdlan challenge vs. control group. (D) Number of bone marrow adipocytes ghosts (left) and representative
histology sections (right) from femur in SKG mice at 3 and 6 weeks post-curdlan challenge vs. control group stained with von Kossa/toluidine blue (scale bar: 100
μm). Results are presented as individual dots with the mean indicated as horizontal line (n=4-6 per group). *p < 0.05, **p ≤ 0.01, and ***p ≤ 0.001 vs. controls via
two-way ANOVA with Tukey’s post hoc test (A, B) and one-way ANOVA with Tukey’s post hoc test (C, D).TABLE 1 | Body weight and serum fat parameters in no-transgenic and
HLA-B27 transgenic rats.
Parameters NTG N = 8 B27 N = 6 p-value
Weight (g) 349 ± 101 248 ± 50.0 0.046
Serum glucose (mmol/L) 14.7 ± 2.25 11.8 ± 1.67 0.031
Triglycerides (mmol/L) 1.93 ± 0.87 1.00 ± 0.46 0.036
Cholesterol (mmol/L) 2.99 ± 0.98 1.65 ± 0.29 0.007
LDL (mmol/L) 0.37 ± 0.09 0.23 ± 0.11 0.032
HDL (mmol/L) 1.75 ± 0.36 1.04 ± 0.25 0.002June 2021 | Volume 12 | ArticleNTG, non-transgenic rat; B27, HLA-B27 transgenic rat; LDL, low-density lipoprotein;
HDL, high-density lipoprotein. Data are represented as mean ± SD.665208




FIGURE 3 | Chronic inflammation in rodent models of SpA leads to loss of white adipose tissue. (A, B) Fat mass, number, and size of adipocytes in subcutaneous
(top) and peri-gonadal (bottom) adipose tissue of NTG and B27 rats. (C, D) Representative histology sections stained with hematoxylin/eosin staining. Scale bars:
100 mm (n=6-8 per group). (E, F) Bodyweight and visceral fat weight of SKG mice at 3- and 6-weeks post-curdlan challenge vs. control group (n=4-6 per group).
Results are presented as individual dots with the mean indicated as horizontal line. **p ≤ 0.01, and ***p ≤ 0.001 vs controls via unpaired Student´s t-test (A, B) and
one-way ANOVA with Tukey’s post hoc test (E, F).A B
D
C
FIGURE 4 | Altered metabolic profile in B27 transgenic rats. (A) Serum concentrations of adiponectin in NTG and B27 rats (n=5-7 per group). (B) Significantly
regulated cytokines in the serum of NTG and B27 rats. (C) Representative image of cytokine profiler array results from serum of NTG and B27 rats. Significant ones
are highlighted. (D) Relative levels of not-regulated obesity-related cytokines in NTG and B27 rats (B,D n=6-8 per group). Data are presented as mean ± SD. *p ≤ 0.05
and **p ≤ 0.001 NTG vs. B27 via unpaired Student’s t-test.Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 6652086
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(Figure 4D).
Hematopoietic Composition of the Bone
Marrow and Blood of B27 Rats
As dysregulated hematopoiesis occurs in several chronic
inflammatory diseases, we analyzed immune cell populations
present in the bone marrow and assessed hematological
parameters in the blood. The frequency of neutrophils was
significantly increased in the bone marrow, mostly due to an
increase in the promyeloid stage and the segmented neutrophils
(Supplementary Figure 1A). In contrast, lymphocytes and
monocytes frequencies were decreased (Supplementary Figure 1B).
Leukocyte numbers were increased by 3-fold in the peripheral
blood of B27 animals, showing significantly increased numbers
in neutrophils, eosinophils, monocytes, and platelets (Table 2).
As expected, erythroid precursors in the bone marrow were
significantly reduced, as was the hematocrit and the mean
corpuscular volume, indicating that anemia of inflammation
had developed in B27 rats (Figure 1 and Table 2). Thus,
during inflammation, neutrophils appear to account for most
of the inflammatory cells in the bone marrow of B27 rats.
Elevated Levels of IL-17 May Contribute to
the Loss of Adipocytes in B27 Rats
As B27 rats have been shown to have an increased prevalence of
CD4+ T-helper 17 (Th17) cells and elevated serum levels of IL-17
(24, 25), we investigated the absolute number of CD4+ T present
in the bone marrow and used mesenteric lymph nodes (mLN) as
a control with a known expansion of Th17 cells. Absolute
numbers of CD4+ T cells were significantly higher in mLN of
spondyloarthritic B27 compared to the healthy NTG rats (Figure
5A), while similar numbers were found in the bone marrow
(Figure 5B). Importantly, the frequency of IL-17-producing
CD4+ T cells was significantly increased in both mLN and
bone marrow of B27 rats compared to NTG rats (Figures 5C,Frontiers in Immunology | www.frontiersin.org 7D). Accordingly, B27 rats showed an 8-fold higher serum level of
IL-17 than NTG (Figure 6A). Given that IL-17 reduces
preadipocyte differentiation and alters adipogenesis (26, 27),
we examined whether this cytokine could be involved in the
depletion of BMAT in our model. For this, we first tested
whether IL-17 indeed suppresses adipogenesis of 3T3
adipocytes. Treatment of 3T3 cells with IL-17 during the
differentiation period reduced in a dose-dependent manner
adipocyte numbers (Figure 6B). Importantly, treatment of 3T3
cells with 5% serum from B27 rats starting at day 3 of
differentiation reduced adipocyte number and the mRNA
expression of adipocyte markers compared to cells treated with
5% NTG serum (Figures 6C, D). This effect with sera was
reversed when cells were incubated with a neutralizing IL-17
antibody confirming the critical role of IL-17 in the regulation of
adipocyte differentiation (Figure 6E). Notably, treating
adipocyte cultures on day 2 post-differentiation with rat serum
did not result in altered adipocyte numbers (NTG: 120.7 ± 13.7
vs. B27: 101.3 ± 38.9 adipocytes, p=0.43). Thus, these data
suggest that the high amount of IL-17 present in the serum of
B27 reduces adipogenesis.DISCUSSION
The ability of BMAds to concurrently influence bone remodeling
and hematopoiesis (7, 8) places them in a crucial position in the
regulation of bone and immune cell fate. Notably, recent
evidence demonstrated that BMAds play a decisive role in
regulating immune responses, contributing to increased levels
of pro-inflammatory cytokines and oxidative stress (6). However,
how chronic inflammation affects BMAT is currently unknown.
We previously observed a drastic reduction of BMAd with
disease duration in B27 rat, while studying the impact of
chronic inflammation on bone in this model of SpA (23).
Here, we examined in more detail the femoral and vertebral
BMAT content in 2 and 6 months old B27 rats. Using 3D µCT
and histology, we showed that BMAT was reduced by up to 90%
in 6-month-old B27 rats with established disease in the femur
and vertebral body compared to control NTG. This finding was
not restricted to the B27 rat model of SpA, since similar findings
were also observed in curdlan-challenged SKG mice, suggesting
that depletion of BMAT is a common characteristic of SpA
rodent models.
Weight loss and decrease in lean mass have been commonly
described in individuals with inflammatory rheumatic disorders,
reflecting their consumptive nature (28, 29). Based on this
clinical evidence, we quantified total body weight as well as
subcutaneous and peri-gonadal fat weight to assess whether the
loss of BMAds is site-specific. Both B27 rats and SKG mice
showed a significant body weight and overall fat mass loss. Thus,
these data show that the decreased amount of BMAT is not a
localized, but rather a systemic phenomenon, and that also white
adipose tissue decreases during chronic inflammation.
Consistently, proteomic analyses showed low serum levels of
adipokines in B27 rats compared to NTG. Interestingly,
reduction of both adiponectin and leptin has been associatedTABLE 2 | Blood differential in no-transgenic and HLA-B27 transgenic rats.
Parameters NTG N = 8 B27 N = 5 p-value
Hematocrit (%) 47.6 ± 4.37 41.4 ± 3.50 0.025
Hemoglobin (g/dl) 14.8 ± 2.68 14.2 ± 2.87 0.787
MCV (fl) 53.4 ± 1.98 50.4 ± 2.07 0.029
MCH (pg) 16.6 ± 2.00 16.4 ± 0.55 0.813
MCHC (g/dl) 31.4 ± 3.82 32.4 ± 1.34 0.567
Erythrocytes (105 #/mm³) 88.9 ± 6.99 81.3 ± 9.08 0.117
Leucocytes (10³ #/mm³) 4.22 ± 2.50 11.6 ± 1.35 <0.001
Neutrophils (10³ #/mm³) 1.50 ± 1.30 20.6 ± 15.4 0.053
Eosinophils (#/mm³) 26.5 ± 27.1 115 ± 13.7 <0.001
Basophils (#/mm³) 22.5 ± 48.5 24.6 ± 55.0 0.944
Lymphocytes (10³ #/mm³) 2.36 ± 1.26 3.52 ± 0.96 0.109
Monocytes (#/mm³) 59.3 ± 56.3 425 ± 241 0.002
Platelets (105 #/mm³) 7.10 ± 1.31 9.60 ± 1.06 0.006NTG, non-transgenic rat; B27, HLA-B27 transgenic rat; MCV, mean corpuscular volume;
MCH, mean corpuscular hemoglobin; MCHC,: mean corpuscular hemoglobin content.
Data are represented as mean ± SD.
Bold values mean they are statistically significant.June 2021 | Volume 12 | Article 665208
Furesi et al. Bone Marrow Fat in SpAwith increased inflammatory responses and enhanced
susceptibility to the toxicity of proinflammatory stimuli,
respectively (29, 30).
In addition, high inflammation reduces circulating levels of
lipids (31–33). Analysis of the serum lipid profile in B27 rats
revealed marked dyslipidemia with decreased triglycerides,
cholesterol, and associated lipoproteins as compared to the
controls. Reduction in HDL cholesterol levels in our rat model
appeared consistent with clinical observations previously
reported (34). Indeed, patients affected by axial SpA and
psoriatic arthritis present with an abnormal lipid profile and
low HDL levels, which have been linked to accelerated
manifestations of cardiovascular diseases and reduced lifespan
(35). Nevertheless, the molecular factors that potentially mediate
the interaction between inflammatory disease and altered lipid
metabolism require further investigations. A plausible
explanation is that proinflammatory cytokines may redirect
energy consumption in favor of hematopoietic cells at the
expense of fat tissue, thereby guaranteeing that enough energy
can be provided to immune cells in states of high demand, such
as during inflammation (36). Thus, cytokines might have direct
effects on lipid metabolism as well as glucose metabolism, which
can also explain the significant reduction of blood glucose levels
in B27 rats as compared to the healthy controls.Frontiers in Immunology | www.frontiersin.org 8Although the immune cell network that drives SpA is still
unclear, experimental evidence supports a central role for HLA-B27
expressing hematopoietic cells in disease development (37).
Therefore, to gain a greater understanding of the hematopoietic
cell composition and explore which other cells inhabit the bone
marrow instead of the BMAds, we analyzed immune cell
populations in B27 rats. Systemic inflammation was associated
with an increased number of mature neutrophils, which was
mirrored by decreased erythroid precursors. These data support
previous findings, in which non-resolving joint and intestinal
inflammation in the SKG mouse model of SpA was accompanied
by dysregulated hematopoietic stem cell activity and biased
differentiation toward myeloid progenitors, culminating in an
invasion of target organs by activated neutrophils (38). Within
the same study, the authors demonstrated that CD4+ T-cell
depletion was not required for the development of SpA in this
model, supporting the critical function of innate versus adaptive
immune response in inflammation (38). Nevertheless, the critical
contribution of adaptive cells to the disease has been shown in
other situations such as in HLA-B27 transgenic rats (12). This leads
to the production of proinflammatory cytokines implicated in the
pathogenesis of SpA. In particular, IL-17 derived from CD4+Th17
has been found to positively correlate with disease severity. Indeed,
serum concentrations of IL-17 were higher in patients with SpAA B
D
C
FIGURE 5 | Expansion of IL17+ producing CD4+ T cells in the bone marrow from B27 transgenic rats. (A) Absolute number of live cells and CD4+ T cells in
mesenteric lymph nodes (mLN) from NTG (grey) and B27 (white) rats were determined using flow cytometry. (B) Absolute number of live cells and CD4+ T cells in
bone marrow (BM) from NTG and B27 rats. (C) Representative plots of intracellular IL-17 staining gated on CD4+ Foxp3- T cells in mLN (top) and BM (bottom) from
NTG (left panel) or B27 (right panel) rats. (D) Frequencies of IL-17+ cells among CD4+ T cells (left) and their absolute numbers (right) in mLN (top) and BM (bottom)
from NTG and B27 rats (A-D n=4-5 per group). Results are presented as individual dots with the mean indicated as horizontal line. Data were analyzed by unpaired
Student’s t-test (*p<0.05, **p < 0.01 and ****p < 0.0001).June 2021 | Volume 12 | Article 665208
Furesi et al. Bone Marrow Fat in SpAthan in age and sex-controlled healthy individuals (39, 40). These
observations are congruent with our analysis, where B27 rats
displayed higher levels of IL-17 in the serum as compared to the
NTG controls. In addition, insights into the molecular regulation of
bone homeostasis revealed that IL-17 steers mesenchymal stem
cells into an osteogenic fate and promote osteoclastogenesis in a
RANKL-dependent manner (16, 41). Further, in vivo studies
implicate IL-17 in the regulation of adipogenesis by inhibiting
preadipocyte differentiation, hampering metabolic function of
mature adipocytes, and consequentially reducing white adipose
tissue accumulation (16, 42). Accordingly, our in vitro experiment
confirmed a significant reduction in the number of adipocytes after
treatment with recombinant IL-17 as well as after treatment with
B27 rat serum. This effect was only observed, however, when
starting the treatment early during the differentiation process.
The reduction of adipocytes was dependent on the IL-17 present
in the serum of B27 rats, as suppression of adipogenesis was
reversed when IL-17 was neutralized using antibodies. Whether
IL-17 mediates the reduction of BMAT during chronicFrontiers in Immunology | www.frontiersin.org 9inflammation in SpA in vivo and whether this is driven by
suppression of BMAT expansion and/or loss of mature BMAds
remains to be investigated.
Besides its prominent role in the regulation of adipose tissue
and energy homeostasis, IL-17 has been shown to activate innate
immune mechanisms, including the recruitment and survival of
neutrophils (13, 43, 44). Thus, the high levels of IL-17 could
explain the reduction of BMAds and the increase of neutrophils
within the bone marrow in our rat model. In fact, the abundance
of IL-17-producing CD4+ T cells observed in the bone marrow of
B27 rats may promote the accumulation of neutrophils and,
simultaneously, induce lipolysis in the surrounded adipocytes to
provide energy for the immune system. Clearly, further
investigations are necessary to thoroughly address this
hypothesis and clarify the mechanisms and purpose of BMAd
reduction during chronic inflammation.
Despite strong evidence that BMAT is reduced in rodentmodels
of SpA, our study has potential limitations. First, our animal models




FIGURE 6 | IL-17 from B27 transgenic rat serum inhibits adipogenesis in vitro. (A) IL-17 levels in sera of in B27 and NTG rats (n=6-7 per group). (B) Absolute
numbers of 3T3 adipocytes after exposure to control medium or increasing doses of IL-17 during adipocyte differentiation (n=3-6 per group). (C, D) Absolute
numbers of 3T3 adipocytes and relative expression of the most representative adipocyte markers after 48 h exposure to 5% serum from NTG rats, B27 rats + IgG
antibody (IgG-Ab), or B27 rats + neutralizing anti-IL-17 antibody (IL-17-Ab) treatment (n=3-6 per group). (E) Representative fluorescence microscopy pictures of
LipidTOX stained 3T3 cells. Scale bar: 50 μm. All experiments were performed independently three times. Results are presented as individual dots with the mean
indicated as horizontal line. *p ≤ 0.05 and **p ≤ 0.01 NTG vs. B27 via unpaired Student’s t-test (A). and one-way ANOVA with Tukey’s post hoc test (B–D).June 2021 | Volume 12 | Article 665208
Furesi et al. Bone Marrow Fat in SpApatients with SpA. For example, osteophytes and fatty streaks at the
vertebral column are rarely observed. Moreover, we evaluated
adipokines in the serum. However, other fat depots such as white
adipose tissue also produce adipokines that are released into the
circulation. Therefore, it would be interesting to analyze adipokine
concentrations directly in the bone marrow microenvironment to
better address which adipokines are locally altered by
chronic inflammation.CONCLUSIONS
Our results show a significant reduction of white adipose tissue
and BMAT in two relevant rodent models of SpA. Elevated
serum levels of IL-17 suggest a potential role of IL17+CD4+ T
cells in sustaining inflammation by disrupting BMAT.DATA AVAILABILITY STATEMENT
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42. Zúñiga LA, Shen W-J, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thom C,
et al. IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity.
J Immunol (2010) 185:6947–59. doi: 10.4049/jimmunol.1001269
43. Flannigan KL, Ngo VL, GeemD, Harusato A, Hirota SA, Parkos CA, et al. Il-17A-
mediated Neutrophil Recruitment Limits Expansion of Segmented Filamentous
Bacteria. Mucosal Immunol (2017) 10:673–84. doi: 10.1038/mi.2016.80
44. Griffin GK, Newton G, Tarrio ML, Bu D, Maganto-Garcia E, Azcutia V, et al.
Il-17 and Tnfa Sustain Neutrophil Recruitment During Inflammation
Through Synergistic Effects on Endothelial Activation. J Immunol Baltim
Md 1950 (2012) 188:6287–99. doi: 10.4049/jimmunol.1200385
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Furesi, Fert, Beaufrère, Araujo, Glatigny, Baschant, von Bonin,
Hofbauer, Horwood, Breban and Rauner. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication in
this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.June 2021 | Volume 12 | Article 665208
